Skip to main content
Equibles
OABIW logo

OABIW · OmniAb, Inc.

Track OABIW — free

Use OABIW with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about OABIW

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$0.05 At close · Aug 6
Market Cap
$6.56M
Shares
145.39M

Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Upcoming events

Date Event Type
2026-10-06 15:00 UTC Investor and Analyst Day Presentation

Recent news

Date Headline
2026-08-06 OmniAb Reports Second Quarter 2026 Financial Results and Business Highlights
2026-07-16 OmniAb to Report Second Quarter 2026 Financial Results on August 6
2026-07-13 OmniAb Names Amechi Nwachuku Chief Operating Officer
2026-05-07 OmniAb Reports First Quarter 2026 Financial Results and Business Highlights
2026-04-24 OmniAb to Participate in Three Upcoming Investor Conferences
2026-04-21 OmniAb to Report First Quarter 2026 Financial Results on May 7
2026-03-04 OmniAb Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
2026-02-24 OmniAb to Participate at the Leerink Partners Global Healthcare Conference
2026-02-19 OmniAb to Report Fourth Quarter 2025 Financial Results on March 4
2025-12-15 Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies
2025-12-04 OmniAb to Hold OmniUltra Virtual Investor Event on December 15
2025-11-17 OmniAb Enters into a Technology License and Services Agreement for Antibody Discovery with a Newly-Formed Incubated Company of ArrowMark Partners and Viking Global Investors
2025-11-04 OmniAb Reports Third Quarter 2025 Financial Results and Business Highlights

Past events

Date Event Type
2026-08-06 Q2 2026 Financial Results and Business Update Call Earnings call
2026-06-02 Jefferies Global Healthcare Conference Conference
2026-05-28 Benchmark 6th Annual Healthcare House Call Virtual Investor Conference Conference
2026-05-07 Q1 2026 Financial Results & Business Update call Earnings call
2026-05-06 H.C. Wainwright 2nd Annual Royalty Company Virtual Conference Conference
2026-03-10 Leerink Partners Global Healthcare Conference Conference
2026-03-04 Q4 2025 Financial Results & Business Update call Earnings call
2025-12-15 OmniUltra Launch Virtual Investor Event Event
2025-11-17 Jefferies Global Healthcare Conference – London Conference
2025-11-11 Stifel 2025 Healthcare Conference Conference
2025-11-06 2025 Truist Securities BioPharma Symposium Event
2025-11-04 Q3 2025 Financial Results & Business Update call Earnings call
2025-09-09 H.C. Wainwright 27th Annual Global Investment Conference Conference
2025-08-06 Q2 2025 Financial Results & Business Update call Earnings call
2025-06-05 Jefferies Global Healthcare Conference Conference
2025-05-29 Benchmark 2025 Healthcare House Call Virtual Conference Conference
2025-05-21 RBC Capital Markets Global Healthcare Conference Conference
2025-05-20 H.C. Wainwright 3rd Annual BioConnect Investor Conference at Nasdaq Conference
2025-05-13 H.C. Wainwright 1st Annual Royalty Company Virtual Conference Conference
2025-05-08 Q1 2025 Financial Results & Business Update earnings call Earnings call
2025-03-18 Q4 2024 Financial Results & Business Update earnings call Earnings call
2024-11-19 Stifel 2024 Healthcare Conference Conference
2024-11-19 Jefferies London Healthcare Conference Conference
2024-11-12 Q3 2024 Financial Results & Business Update earnings call Earnings call
2024-09-19 Craig-Hallum Bioprocessing Virtual Conference Conference

Source: https://investors.omniab.com/overview/default.aspx

Key facts CIK 1846253 CUSIP 68218J111 13F (30d) 139 filings 137 filers Visit website Investor relations

Report a Problem

Category
Description
Email (optional, for follow-up)